In contrast to our findings, a study from 2022, conducted in Chicago, reported that antibodies against S protein did not increase significantly in a group of previously infected COVID-19 patients after the second vaccine dose (i.e., third antigen exposure) [3]. The gene discussed is PROS1; the disease is COVID-19.